Literature DB >> 34846884

Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket.

Matthew G Lloyd, Rosemary Huckvale, Kwai-Ming J Cheung, Matthew J Rodrigues, Gavin W Collie, Olivier A Pierrat, Mahad Gatti Iou, Michael Carter, Owen A Davis, P Craig McAndrew, Emma Gunnell, Yann-Vaï Le Bihan, Rachel Talbot, Alan T Henley, Louise D Johnson, Angela Hayes, Michael D Bright, Florence I Raynaud, Mirco Meniconi, Rosemary Burke, Rob L M van Montfort, Olivia W Rossanese, Benjamin R Bellenie, Swen Hoelder.   

Abstract

We describe the optimization of modestly active starting points to potent inhibitors of BCL6 by growing into a subpocket, which was occupied by a network of five stably bound water molecules. Identifying potent inhibitors required not only forming new interactions in the subpocket but also perturbing the water network in a productive, potency-increasing fashion while controlling the physicochemical properties. We achieved this goal in a sequential manner by systematically probing the pocket and the water network, ultimately achieving a 100-fold improvement of activity. The most potent compounds displaced three of the five initial water molecules and formed hydrogen bonds with the remaining two. Compound 25 showed a promising profile for a lead compound with submicromolar inhibition of BCL6 in cells and satisfactory pharmacokinetic (PK) properties. Our work highlights the importance of finding productive ways to perturb existing water networks when growing into solvent-filled protein pockets.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34846884      PMCID: PMC8667045          DOI: 10.1021/acs.jmedchem.1c00946

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  21 in total

Review 1.  The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.

Authors:  Fabrice Jardin; Philippe Ruminy; Christian Bastard; Hervé Tilly
Journal:  Pathol Biol (Paris)       Date:  2006-07-03

Review 2.  Applications of amide isosteres in medicinal chemistry.

Authors:  Shaoyi Sun; Qi Jia; Zaihui Zhang
Journal:  Bioorg Med Chem Lett       Date:  2019-07-22       Impact factor: 2.823

3.  A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.

Authors:  Leandro C Cerchietti; Alexandru F Ghetu; Xiao Zhu; Gustavo F Da Silva; Shijun Zhong; Marilyn Matthews; Karen L Bunting; Jose M Polo; Christophe Farès; Cheryl H Arrowsmith; Shao Ning Yang; Monica Garcia; Andrew Coop; Alexander D Mackerell; Gilbert G Privé; Ari Melnick
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

4.  Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma.

Authors:  Mariano G Cardenas; Wenbo Yu; Wendy Beguelin; Matthew R Teater; Huimin Geng; Rebecca L Goldstein; Erin Oswald; Katerina Hatzi; Shao-Ning Yang; Joanna Cohen; Rita Shaknovich; Kenno Vanommeslaeghe; Huimin Cheng; Dongdong Liang; Hyo Je Cho; Joshua Abbott; Wayne Tam; Wei Du; John P Leonard; Olivier Elemento; Leandro Cerchietti; Tomasz Cierpicki; Fengtian Xue; Alexander D MacKerell; Ari M Melnick
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

5.  Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship.

Authors:  Kotaro Sakamoto; Satoshi Sogabe; Yusuke Kamada; Nozomu Sakai; Kouhei Asano; Mie Yoshimatsu; Kou Ida; Yasuhiro Imaeda; Jun-Ichi Sakamoto
Journal:  Biochem Biophys Res Commun       Date:  2016-11-14       Impact factor: 3.575

Review 6.  Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment.

Authors:  Yang Liu; Stefan Klaus Barta
Journal:  Am J Hematol       Date:  2019-05       Impact factor: 10.047

Review 7.  Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Authors:  Shikha Kumari; Angelica V Carmona; Amit K Tiwari; Paul C Trippier
Journal:  J Med Chem       Date:  2020-08-04       Impact factor: 7.446

8.  Discovery of a B-Cell Lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach.

Authors:  Yusuke Kamada; Nozomu Sakai; Satoshi Sogabe; Koh Ida; Hideyuki Oki; Kotaro Sakamoto; Weston Lane; Gyorgy Snell; Motoo Iida; Yasuhiro Imaeda; Junichi Sakamoto; Junji Matsui
Journal:  J Med Chem       Date:  2017-05-11       Impact factor: 7.446

9.  Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.

Authors:  Jose M Polo; Tania Dell'Oso; Stella Maris Ranuncolo; Leandro Cerchietti; David Beck; Gustavo F Da Silva; Gilbert G Prive; Jonathan D Licht; Ari Melnick
Journal:  Nat Med       Date:  2004-11-07       Impact factor: 53.440

10.  Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.

Authors:  Takeshi Yasui; Takeshi Yamamoto; Nozomu Sakai; Kouhei Asano; Takafumi Takai; Yayoi Yoshitomi; Melinda Davis; Terufumi Takagi; Kotaro Sakamoto; Satoshi Sogabe; Yusuke Kamada; Weston Lane; Gyorgy Snell; Masashi Iwata; Masayuki Goto; Hiroshi Inooka; Jun-Ichi Sakamoto; Yoshihisa Nakada; Yasuhiro Imaeda
Journal:  Bioorg Med Chem       Date:  2017-07-20       Impact factor: 3.641

View more
  2 in total

1.  Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 In Vivo.

Authors:  Rosemary Huckvale; Alice C Harnden; Kwai-Ming J Cheung; Olivier A Pierrat; Rachel Talbot; Gary M Box; Alan T Henley; Alexis K de Haven Brandon; Albert E Hallsworth; Michael D Bright; Hafize Aysin Akpinar; Daniel S J Miller; Dalia Tarantino; Sharon Gowan; Angela Hayes; Emma A Gunnell; Alfie Brennan; Owen A Davis; Louise D Johnson; Selby de Klerk; Craig McAndrew; Yann-Vaï Le Bihan; Mirco Meniconi; Rosemary Burke; Vladimir Kirkin; Rob L M van Montfort; Florence I Raynaud; Olivia W Rossanese; Benjamin R Bellenie; Swen Hoelder
Journal:  J Med Chem       Date:  2022-06-02       Impact factor: 8.039

2.  Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors.

Authors:  Owen A Davis; Kwai-Ming J Cheung; Alfie Brennan; Matthew G Lloyd; Matthew J Rodrigues; Olivier A Pierrat; Gavin W Collie; Yann-Vaï Le Bihan; Rosemary Huckvale; Alice C Harnden; Ana Varela; Michael D Bright; Paul Eve; Angela Hayes; Alan T Henley; Michael D Carter; P Craig McAndrew; Rachel Talbot; Rosemary Burke; Rob L M van Montfort; Florence I Raynaud; Olivia W Rossanese; Mirco Meniconi; Benjamin R Bellenie; Swen Hoelder
Journal:  J Med Chem       Date:  2022-06-03       Impact factor: 8.039

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.